Suppr超能文献

患者报告结局测量与临床医生报告结局在机器人辅助根治性前列腺切除术后局限性前列腺癌中的尿失禁和勃起功能障碍方面的比较:对治疗的影响。

Patient-reported outcome measures compared to clinician reported outcomes regarding incontinence and erectile dysfunction in localized prostate carcinoma after robot assisted radical prostatectomy: Impact on management.

机构信息

Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

出版信息

Urol Oncol. 2023 Nov;41(11):454.e1-454.e8. doi: 10.1016/j.urolonc.2023.08.001. Epub 2023 Sep 9.

Abstract

PURPOSE/ BACKGROUND: Patient-reported outcome measures (PROMs) are widely used after robot assisted radical prostatectomy (RARP) in order to evaluate the impact/burden of the treatment. The most bothersome side effects of RARP are urine incontinence (UI) and erectile dysfunction (ED). During the follow up consultations, clinicians report these side effects in interviewing patients. Our study examined the discrepancy between the PROMs and clinician report outcomes (CROs) and hypothesized that the disagreement could have an impact on the management of UI and ED.

METHODS

Up to 1 year after RARP, UI and ED recovery of 312 men with localized and locally advanced prostate cancer were assessed using the International Consultation Incontinence Questionnaire Short-Form (ICIQ-SF) and the International Index of Erectile Function (IIEF-EF) and CROs by interview. Discrepancies between PROs and CROs were studied in light of treatment offered and management.

RESULTS

The ICIQ-SF Score matched with CROs in all sum score categories except in ICIQ sum score 6 to 12; here the UI was underreported by clinicians in 58% and 59% of patients at 8 and 12 months (P < 0.001). Furthermore, at 8 and 12 months postoperatively, clinicians underreported UI in 29% and 23% of patients with ICIQ score 13-18 (P < 0.001). The clinician significantly over-reported the recovery of erectile function ("normal erection") (P < 0.001), especially in men with IIEF-EF sum score 6 to 16. Independently of ICIQ-SF/IIEF-EF scores, discrepancy between PROs and CROs did not affect rate of health care offered to patients.

CONCLUSIONS

This is to our knowledge the first study that compared the PROs with clinician reported functional outcomes and the impact of discrepancies on the management of side effects of RARP in prostate cancer. Observed discrepancies between the PROs and CROs did not affect offered management and counseling of UI and ED.

摘要

目的/背景:患者报告的结果测量(PROMs)在机器人辅助根治性前列腺切除术(RARP)后被广泛用于评估治疗的影响/负担。RARP 最常见的副作用是尿失禁(UI)和勃起功能障碍(ED)。在随访咨询中,临床医生通过对患者进行访谈来报告这些副作用。我们的研究检查了 PROMs 与临床医生报告结果(CRO)之间的差异,并假设这种差异可能会对 UI 和 ED 的治疗产生影响。

方法

在 RARP 后长达 1 年的时间里,使用国际尿失禁咨询问卷简表(ICIQ-SF)和国际勃起功能指数(IIEF-EF)评估了 312 名局限性和局部进展性前列腺癌患者的 UI 和 ED 恢复情况,并通过访谈评估了 CROs。根据提供的治疗和管理情况研究了 PROs 和 CROs 之间的差异。

结果

ICIQ-SF 评分与所有总分类别中的 CRO 相匹配,除了 ICIQ 总分 6 到 12 分;在这里,在术后 8 个月和 12 个月,临床医生分别有 58%和 59%的患者报告 UI 漏诊(P < 0.001)。此外,在术后 8 个月和 12 个月时,临床医生在 ICIQ 评分 13-18 的患者中分别有 29%和 23%的患者报告 UI 漏诊(P < 0.001)。临床医生显著高估了勃起功能的恢复(“正常勃起”)(P < 0.001),尤其是在 IIEF-EF 总分 6 到 16 的患者中。独立于 ICIQ-SF/IIEF-EF 评分,PROs 和 CROs 之间的差异并不影响为患者提供的保健服务率。

结论

这是我们所知的第一份比较患者报告的结果与临床医生报告的功能结果以及差异对前列腺癌 RARP 副作用治疗的影响的研究。观察到的 PROs 和 CROs 之间的差异并没有影响 UI 和 ED 的管理和咨询。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验